TOKYO -- Japanese biotech venture AnGes is set to begin a clinical trial of a coronavirus vaccine in July, Nikkei learned Monday, raising hopes that the medication could secure government approval by the end of the year.
The clinical trial was originally slated to start in September, but the Ibaraki, Osaka Prefecture-based company has been able to bring forward the schedule, following discussions with regulators and hospitals, thanks to promising results from animal tests, company officials said.
